COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,790 Articles (22,523 medRxiv, 8,267 bioRxiv)

Most recent first Previous |  Page 874: Articles 8731-8740  | Next

Serological responses and six-month trajectories to COVID-19 Comirnaty and Spikevax booster vaccine, September 2021 to January 2022, London, United Kingdom
Ireland, G., Whitaker, H., Ladhani, S., Baawuah, F., Subbarao, S., Elgohari, S., Smith, A., O'Brien, M., Whillock, C., Martin, O., Moss, P., Ramsay, M. E., Amirthalingam, G., Brown, K. E.
10.1101/2022.02.17.22271126 — Posted: 2022-02-18
Reliability of citations of medRxiv preprints in articles published on COVID-19 in the world leading medical journals
Gehanno, J.-F., Grosjean, J., Darmoni, S. J., Rollin, L.
10.1101/2022.02.16.22271068 — Posted: 2022-02-17
Relative Virulence of SARS-CoV-2 Among Vaccinated and Unvaccinated Individuals Hospitalized with SARS-CoV-2
Grima, A., Murison, K., Simmons, A., Tuite, A., Fisman, D.
10.1101/2022.02.15.22271016 — Posted: 2022-02-17
Effectiveness and durability of the mRNA vaccine-induced SARS-CoV-2-specific humoral and cellular immunity in severe asthma patients on biological therapy
Podrazil, M., Taborska, P., Stakheev, D., Rataj, M., Lastovicka, J., Vlachova, A., Pohunek, P., Bartunkova, J., Smrz, D.
10.1101/2022.02.17.22271122 — Posted: 2022-02-17
The public health impact of poor sleep on severe COVID-19, influenza and upper respiratory infections
Jones, S. E., Maisha, F. I., Strausz, S. J., Cade, B. E., Tervi, A. M., Helaakoski, V., Broberg, M. E., Lammi, V., FinnGen, , Lane, J. M., Redline, S., Saxena, R., Ollila, H. M.
10.1101/2022.02.16.22271055 — Posted: 2022-02-17
A novel SEIR-e model for disease transmission and pathogen exposure
Tambyah, T. A., Testolin, M. J., Hill, A. M.
10.1101/2022.02.16.22271093 — Posted: 2022-02-17
Analytical Sensitivity of the SalivaDirect™ Assay on the Liberty16 for detecting SARS-CoV-2 B.1.1.529 Omicron
Tan, Y. P., Al-Halbouni, M., Chen, C.-H., Hirst, D. B., Pickering, P. J.
10.1101/2022.02.16.22271096 — Posted: 2022-02-17
Intramuscular mRNA BNT162b2 vaccine against SARS-CoV-2 induces robust neutralizing salivary IgA
Stolovich-Rain, M., Kumari, S., Friedman, A., Kirillov, S., Socol, Y., Billan, M., Ranjan Pal, R., Golding, P., Oiknine-Djian, E., Sirhan, S., Bejerano Sagie, M., Cohen-Kfir, E., Elgrably-Weiss, M., Zhou, B., Ravins, M., E Gatt, Y., Das, K., Zelig, O., Wiener, R., Wolf, D., Elinav, H., Strahilevitz, J., Padawer, D., Baraz, L., Rouvinski, A.
10.1101/2022.02.17.480851 — Posted: 2022-02-17
An ACE2-blocking antibody confers broad neutralization and protection against Omicron and other SARS-CoV-2 variants
Du, W., Hurdiss, D. L., Drabek, D., Mykytyn, A. Z., Kaiser, F., Gonzalez-Hernandez, M., Munoz-Santos, D., Lamers, M. M., van Haperen, R., Li, W., Drulyte, I., Wang, C., Sola, I., Armando, F., Beythien, G., Ciurkiewicz, M., Baumgartner, W., Guilfoyle, K., Smits, T., van der Lee, J., van Kuppeveld, F. J. M., van Amerongen, G., Haagmans, B. L., Enjuanes, L., Osterhaus, A. D., Grosveld, F., Bosch, B. J.
10.1101/2022.02.17.480751 — Posted: 2022-02-17
A natural broad-spectrum inhibitor of enveloped virus entry, effective against SARS-CoV-2 and Influenza A Virus in preclinical animal models.
Narayan, R., Sharma, M., Yadav, R. T., Biji, A., Khatun, O., Rajmani, R. S., Sharma, P. R., Jeyashankar, S., Rani, P., Rao, C. D., Satchidanandam, V., Das, S., Agarwal, R., Tripathi, S.
10.1101/2022.02.16.480801 — Posted: 2022-02-17

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).